These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38537875)

  • 1. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade.
    Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
    Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc finger protein 367 exerts a cancer-promoting role in small cell lung cancer by influencing the CIT/LATS2/YAP signaling cascade.
    Kong R; Ma Y; Li W; Xu Z; Gong S; Liu A; Cheng C; Zhang X; Qin J; Li S; Feng J; Jiang J
    Toxicol Appl Pharmacol; 2024 Aug; 489():117005. PubMed ID: 38880190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
    Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
    Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
    Cardnell RJ; Feng Y; Mukherjee S; Diao L; Tong P; Stewart CA; Masrorpour F; Fan Y; Nilsson M; Shen Y; Heymach JV; Wang J; Byers LA
    PLoS One; 2016; 11(4):e0152584. PubMed ID: 27055253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer.
    Wang M; You L; Su Z; He Y; Li D; Liu Z
    Sci Rep; 2024 Sep; 14(1):20654. PubMed ID: 39232038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
    Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
    Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
    Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN, P-Akt and m-TOR in different pathological types of lung cancer.
    Zhang B; Zhao Z; Huang Y; Mao H; Zou M; Wang C; Yu G; Zhang M
    BMC Med Imaging; 2021 Apr; 21(1):73. PubMed ID: 33865336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.
    Sen T; Tong P; Diao L; Li L; Fan Y; Hoff J; Heymach JV; Wang J; Byers LA
    Clin Cancer Res; 2017 Oct; 23(20):6239-6253. PubMed ID: 28698200
    [No Abstract]   [Full Text] [Related]  

  • 12. Human Schlafen 5 Inhibits Proliferation and Promotes Apoptosis in Lung Adenocarcinoma via the PTEN/PI3K/AKT/mTOR Pathway.
    Gu X; Zhou L; Chen L; Pan H; Zhao R; Guang W; Wan G; Zhang P; Liu D; Deng LL; Zhao W; Lu C
    Biomed Res Int; 2021; 2021():6628682. PubMed ID: 33860045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.
    Chen R; Li D; Zheng M; Chen B; Wei T; Wang Y; Li M; Huang W; Tong Q; Wang Q; Zhu Y; Fang W; Guo L; Fang S
    J Cell Mol Med; 2020 Feb; 24(3):2123-2134. PubMed ID: 31957179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
    Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
    Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC.
    Cui J; Wang J; Shen Y; Lin D
    Genes Genomics; 2021 Feb; 43(2):105-114. PubMed ID: 33460027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2/mTOR and Akt/c-Myc signaling pathway via GRB10.
    Yu Y; Shang Y; Shi S; He Y; Shi W; Wang M; Wang Q; Xu D; Shi C; Chen H
    Hereditas; 2024 Sep; 161(1):29. PubMed ID: 39223679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.
    Ichikawa T; Nakahata S; Fujii M; Iha H; Morishita K
    Sci Rep; 2015 Aug; 5():12841. PubMed ID: 26269411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.